News

Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...
The results of an international study led by researchers from Queen Mary University of London’s Precision Healthcare ...
The results of the MIROCALS randomised clinical trial showed that adding low-dose interleukin-2 (IL2LD) to standard treatment ...